For Alltrna CEO Michelle Werner, Making Better Drugs Is Personal

Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.

Scroll to Top